ANI Pharmaceuticals Inc (ANIP) — Net Asset Quality Index
ANI Pharmaceuticals Inc (ANIP) has a Net Asset Quality Index of 37.5% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.44 Billion minus total liabilities of $899.65 Million yields net assets of $540.72 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check ANI Pharmaceuticals Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
ANI Pharmaceuticals Inc Net Asset Quality Index Over Time (1998–2025)
This chart shows how ANI Pharmaceuticals Inc's Net Asset Quality Index has evolved across 28 annual periods from 1998 to 2025. As of December 2025, the index stands at 37.5%, representing net assets of $540.72 Million against total assets of $1.44 Billion USD. See working capital to net assets of ANI Pharmaceuticals Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for ANI Pharmaceuticals Inc (1998–2025)
The table below presents the year-by-year Net Asset Quality Index for ANI Pharmaceuticals Inc from 1998 to 2025, covering 28 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see ANIP market cap.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 37.5% | $540.72 Million | $1.44 Billion | $899.65 Million | ▲ +4.2 pp |
| 2024 | 33.4% | $428.53 Million | $1.28 Billion | $855.17 Million | ▼ -17.2 pp |
| 2023 | 50.6% | $457.60 Million | $904.42 Million | $446.82 Million | ▲ +6.1 pp |
| 2022 | 44.5% | $338.54 Million | $760.09 Million | $421.55 Million | ▼ -2.0 pp |
| 2021 | 46.5% | $358.74 Million | $771.60 Million | $412.86 Million | ▲ +4.1 pp |
| 2020 | 42.4% | $195.70 Million | $461.19 Million | $265.49 Million | ▼ -4.2 pp |
| 2019 | 46.6% | $212.79 Million | $456.79 Million | $244.00 Million | ▲ +0.8 pp |
| 2018 | 45.8% | $197.26 Million | $430.60 Million | $233.34 Million | ▲ +3.4 pp |
| 2017 | 42.4% | $174.76 Million | $412.14 Million | $237.38 Million | ▼ -10.1 pp |
| 2016 | 52.5% | $169.65 Million | $322.86 Million | $153.22 Million | ▼ -3.6 pp |
| 2015 | 56.1% | $160.08 Million | $285.26 Million | $125.18 Million | ▲ +3.1 pp |
| 2014 | 53.0% | $139.78 Million | $263.71 Million | $123.92 Million | ▼ -39.0 pp |
| 2013 | 92.0% | $40.96 Million | $44.50 Million | $3.54 Million | ▲ +19.4 pp |
| 2012 | 72.7% | $28.18 Million | $38.77 Million | $10.59 Million | ▲ +12.1 pp |
| 2011 | 60.6% | $37.82 Million | $62.38 Million | $24.56 Million | ▲ +17.9 pp |
| 2010 | 42.8% | $19.15 Million | $44.77 Million | $25.62 Million | ▼ -0.7 pp |
| 2009 | 43.4% | $15.83 Million | $36.44 Million | $20.61 Million | ▼ -34.8 pp |
| 2008 | 78.2% | $13.83 Million | $17.68 Million | $3.85 Million | ▼ -16.9 pp |
| 2007 | 95.1% | $29.73 Million | $31.24 Million | $1.52 Million | ▲ +14.4 pp |
| 2006 | 80.8% | $18.07 Million | $22.37 Million | $4.30 Million | ▲ +9.6 pp |
| 2005 | 71.2% | $6.82 Million | $9.57 Million | $2.76 Million | ▼ -18.1 pp |
| 2004 | 89.3% | $15.92 Million | $17.83 Million | $1.91 Million | ▼ -1.5 pp |
| 2003 | 90.8% | $8.68 Million | $9.57 Million | $881.21K | ▲ +12.2 pp |
| 2002 | 78.6% | $4.62 Million | $5.88 Million | $1.26 Million | ▼ -2.7 pp |
| 2001 | 81.4% | $4.05 Million | $4.98 Million | $927.76K | ▲ +12.1 pp |
| 2000 | 69.3% | $2.13 Million | $3.07 Million | $941.26K | ▼ -25.0 pp |
| 1999 | 94.3% | $5.45 Million | $5.78 Million | $329.12K | ▲ +18.0 pp |
| 1998 | 76.3% | $2.63 Million | $3.45 Million | $817.91K | — |